糖皮质激素在脓毒性休克中争议性作用
本文通过PubMed的Mesh数据库检索近10年成人、英文、人类研究,检索词为「脓毒性休克」及「治疗用途」「药物治疗」「药理学」「治疗」等副主题词并加上「类固醇」,共审查165篇文章,25篇纳入综述。这25篇文章关于糖皮质激素在脓毒性休克中有用性的证据相互矛盾;若干研究显示生理学结局改善,包括器官衰竭发生率、生命支持干预需求、不良反应、炎症标志物及休克过程中的灌注,并且在有统计学显著性的患者数量中死亡率降低。结论认为脓毒性休克患者仍需改进治疗,糖皮质激素在改善死亡率和临床标志物方面显示出一定潜力,需要进一步研究确定其在脓毒性休克中的最佳作用。
要点
- 综述纳入25篇文章,关于糖皮质激素在脓毒性休克中有用性的证据相互矛盾。
- 若干研究显示糖皮质激素改善生理学结局,包括器官衰竭发生率、生命支持干预需求、不良反应、炎症标志物及灌注。
- 在有统计学显著性的患者数量中,糖皮质激素与死亡率降低相关。
- 综述指出小剂量糖皮质激素对脓毒性休克患者有中等获益的证据。
- 需要进一步研究确定糖皮质激素在脓毒性休克中的最佳作用。
适用人群与场景
- 成人(18岁以上)脓毒性休克患者,英文、人类研究,近10年内发表。
研究设计与关键结果
- 研究类型为文献综述,检索PubMed的Mesh数据库,检索词为「脓毒性休克」及副主题词「治疗用途」「药物治疗」「药理学」「治疗」并加上「类固醇」,限制为18岁以上、英文、人类研究及近10年内发表。
- 共审查165篇文章,25篇被认为与综述相关。
- 25篇文章关于糖皮质激素在脓毒性休克中有用性的证据相互矛盾。
- 若干研究显示生理学结局改善,包括器官衰竭发生率、生命支持干预需求、不良反应、炎症标志物及脓毒性休克过程中的灌注。
- 在有统计学显著性的患者数量中,糖皮质激素与死亡率降低相关。
证据类型、等级与局限
- 证据类型:文献综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 综述结论认为脓毒性休克患者仍需改进治疗,糖皮质激素在改善死亡率和临床标志物方面显示出一定潜力,但需要进一步研究确定其在脓毒性休克中的最佳作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several clinical trials and literature reviews have been conducted to evaluate the impact of corticosteroids on the physiological markers and clinical outcomes of patients in septic shock. While the findings have been somewhat contradictory, there is evidence of moderate benefit from the administration of low-dose corticosteroids to patients in septic shock. In this review, we discuss recent studies evaluating the impact of corticosteroids on morbidity and mortality in septic shock and explore future directions to fully elucidate when and how the administration of corticosteroid therapies can be beneficial.
METHODS: A literature review was performed using the Mesh database of PubMed with the term "septic shock" and subheadings "therapeutic use", "drug therapy", "pharmacology", and "therapy" followed by the addition of "steroid". Filters were added to restrict the search to 18+ age, English and human studies, and articles published within the last 10 years. One hundred sixty-five articles were examined and twenty-five were deemed relevant to this review.
RESULTS: The twenty-five articles reviewed here provide conflicting evidence as to the usefulness of corticosteroid treatments during septic shock. Several showed improved physiological outcomes, including rates of organ failure, need for life supporting interventions, adverse effects, inflammatory markers, and perfusion during the course of septic shock, as well as decreased mortality for a statistically significant number of patients.
CONCLUSIONS: There remains a need for improved therapy for patients in septic shock. Corticosteroids have shown some potential in improving mortality rates and clinical markers. Additional studies are needed to determine the optimal role of corticosteroids in septic shock.
参考来源
- Pourmand A, Whiteside T, Yamane D, et al. The controversial role of corticosteroids in septic shock. Am J Emerg Med. 2019. PMID: 31056383. doi:10.1016/j.ajem.2019.04.045
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。